Active, Not Recruiting
Zimberelimab Plus Lenvatinib After Progression on Prior Immune Checkpoint Inhibitors for Advanced Cervical Cancer
NCT05824468
- Conditions
- Cervical Cancer, Cervical Carcinoma, Female Urogenital Diseases, +12 more
- Locations
-
- Sun Yat-sen University Cancer Cetntre Guangzhou, China